Effects of amphetamine on serotoninergic and GABAergic expression of developing brain

Psychostimulant drug effects on glutamate, Glx, and creatine in the anterior cingulate cortex and subjective response in healthy humans

Prescription psychostimulants produce rapid changes in mood, energy, and attention. These drugs are widely used and abused. However, their effects in human neocortex on glutamate and glutamine (pooled as Glx), and key neurometabolites such as N-acetylaspartate (tNAA), creatine (tCr), choline (Cho), and myo-inositol (Ins) are poorly understood. Changes in these compounds could inform the mechanism of action of psychostimulant drugs and their abuse potential in humans. We investigated the acute impact of two FDA-approved psychostimulant drugs on neurometabolites using magnetic resonance spectroscopy (¹H MRS). Single clinically relevant doses of d-amphetamine (AMP, 20 mg oral), methamphetamine (MA, 20 mg oral; Desoxyn®), or placebo were administered to healthy participants (n = 26) on three separate test days in a placebo-controlled, double-blinded, within-subjects crossover design. Each participant experienced all three conditions and thus served as his/her own control. ¹H MRS was conducted in the dorsal anterior cingulate cortex (dACC), an integrative neocortical hub, during the peak period of drug responses (140-150 m post ingestion). D-amphetamine increased the level of Glu (p = .0001), Glx (p = .003), and tCr (p = .0067) in the dACC. Methamphetamine increased Glu in females, producing a significant crossover interaction pattern with gender (p = .02). Drug effects on Glu, tCr, and Glx were positively correlated with subjective drug responses, predicting both the duration of AMP liking (Glu: r = +.49, p = .02; tCr: r = +.41, p = .047) and the magnitude of peak drug high to MA (Glu: r = +.52, p = .016; Glx: r = +.42, p = .049). Neither drug affected the levels of tNAA, Cho, or Ins after correction for multiple comparisons. We conclude that d-amphetamine increased the concentration of glutamate, Glx, and tCr in the dACC in male and female volunteers 2¹/₂ hours after drug consumption. There was evidence that methamphetamine differentially affects dACC Glu levels in women and men. These findings provide the first experimental evidence that specific psychostimulants increase the level of glutamatergic compounds in the human brain, and that glutamatergic changes predict the extent and magnitude of subjective responses to psychostimulants.

Amphetamine differentially modifies the expression of monoaminergic and GABAergic synaptic boutons and processes in lateral habenula, dorsal and ventral hippocampal formation

The habenular complex is thought to be associated with cognitive functions and indirectly connected with the hippocampal formation (HF). Thus the responses of the monoaminergic and GABAergic neurons were examined in both structures to the psychostimulant, amphetamine (Amph). Immunocytochemical analysis was performed on brain sections prepared from adult mice treated with a single or multiple (2 doses/day, 7 doses in total) injections of saline or Amph, 5mg/kg. The synaptic boutons were verified by immuno-electron microscopy specific for parvalbumin (PV), glutamic acid decarboxylase(67) (GAD(67)), aromatic amino acid decarboxylase (AADC) or dopamine-β-hydroxylase (DBH). In the lateral part of the lateral habenula (LHb), at 4h post-acute Amph, the densities of PV-positive boutons/processes and DBH-boutons were decreased by approximate 75% and 72% respectively, compared with corresponding saline-controls; however, at 4h post-repeated Amph exposure, PV was increased by 244%, and DBH unaltered. In the dorsal HF (DHF), at 4h post-repeated Amph exposure, GAD(67)-boutons and PV resembled controls in CA1 and CA3 pyramidal cell layers, whereas in the granule cell layer of dentate gyrus (DG), PV was increased by 112%, and GAD(67) unchanged. As shown by biochemical methods, at 4h post-repeated Amph, the decreased level of DHF GABA probably correlates with the immunocytochemical changes. In the ventral HF (VHF), at 4h post-repeated Amph treatment, PV and the enzymes of CA1 and DG were unaltered, while CA3 PV was decreased by 63%, and AADC-boutons increased 55%. Double immuno-electron microscopy revealed synaptic contacts between PV and GAD(67) containing presynaptic or postsynaptic elements, and between PV or GAD(67) and DBH or AADC. This ultrastructural evidence may support the functional significance of the Amph-induced differential changes, which could reflect Amph toxicity and distinct characteristics of the LHb, DHF and VHF.

MK801-induced activated caspase-3 exhibits selective co-localization with GAD67

Blockade of the N-methyl-d-aspartate receptor (NMDAR) in postnatal day 7 (P7) rats can promote rapid and robust induction of the pro-apoptotic marker activated caspase-3 (AC3) and loss of the GABAergic marker GAD67 at P56. Thus, we hypothesized that NMDAR blockade-induced AC3 occurs in GAD67 positive cells at P7. To test this idea, we injected P7 rat pups with vehicle or MK801 and after 8h (peak of AC3 induction) we examined brain sections for both AC3 and GAD67. Compared to vehicle, MK801 profoundly induced AC3 in all brain regions examined but co-expression of GAD67 in the same cells was not observed. However, in brain regions where punctate (synaptic) GAD67 was abundant (for example, layer IV of the somatosensory cortex), AC3 was robust. These data suggest that whereas somatic expression of AC3 and GAD67 may be non-overlapping, areas that exhibit punctate GAD67 (and are high in synaptic turnover) may be more vulnerable to MK801 exposure.

Differential alterations in the relations among GABAergic, catecholaminergic and calcium binding protein expression in the olfactory bulb of amphetamine-administered mouse

This study explores cellular responses of distinct layers of the main olfactory bulb (OB) to amphetamine (Amph), by examining the expression of glutamic acid decarboxylase67 (GAD67), calcium binding proteins (CaBP) and tyrosine hydroxylase (TH). Immunocytochemical analysis was performed on OB sections prepared from adult mice at 0.5 h or 4 h after receiving one intraperitoneal injection or multiple (2 doses/day, 7 doses in total) injections of saline or Amph, 5 mg/kg. In the glomerular layer, though the expression of TH and GAD67 was unaltered by the single Amph injection, at 0.5 h post-repeated Amph exposure the levels of TH-immunopositive somata and processes/punctates, and GAD67-somata/punctates were increased by 48-147%, compared with respective saline controls. By contrast, at 4 h post-repeated Amph GAD67 levels were lower than saline, and TH similar to saline. For the repetitively saline-injected groups, TH and GAD67 levels were higher at 4h than 0.5 h, suggesting an injection-associated stress response. Double staining revealed that at 0.5h post-repeated Amph exposure, the percentage of TH-soma number that expressed GAD67 was raised to 46%, compared with 30% of the corresponding saline, and thus implies an activation of dopaminergic neurons to become GABAergic. In the external plexiform layer, the numbers of CaBP, parvalbumin or calretinin-somata were increased at 0.5 h/4 h or 4 h post-acute Amph injection; double staining disclosed that at 4 h post-acute Amph, 66% or 47% of GAD67-somata contained parvalbumin or calretinin, being greater than 43% or 28% of the saline. In the granule somata, Amph probably inhibits expression of GAD67 by decreasing phosphorylation of CREB (pCREB). The up-regulation of CaBPs, GAD67 and TH at 0.5/4 h post-acute or 0.5 h post-repeated Amph could implicate protective roles and synaptic plasticity against Amph, whereas decreases of GAD67 and pCREB at 4 h post-repeated Amph may indicate toxicity of Amph.